SYRS - Syros Pharmaceuticals files for $250M mixed shelf offering - filing
2023-04-06 16:23:10 ET
- Syros Pharmaceuticals ( NASDAQ: SYRS ) on Thursday disclosed in an SEC filing a prospectus for a proposed mixed shelf offering to raise $250 million.
- The company expects to offer debt securities, common stock, preferred stock, units, and warrants under the offering.
- SEC filing .
For further details see:
Syros Pharmaceuticals files for $250M mixed shelf offering - filing